Live feed
Filing
SC 13G
SC 13G0001011438-20-000164·SOROS FUND MANAGEMENT LLC
Schedule 13G ownership disclosure
XERIS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 98422L107
Event date: 2020-06-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,487,581
- Percent of class
- 5.2600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001011438-20-000164
- Form type
- SC 13G
- Filer
- SOROS FUND MANAGEMENT LLC
- CIK
- CIK 1029160
- Filed
- Jul 10, 2020
- Reporting period
- Jun 30, 2020
- Description
- Schedule 13G beneficial ownership